Elevance Health Inc.
Elevance Health Reports 2Q 2025 Financial Results
Summary
Elevance Health, Inc. reported its second-quarter 2025 financial results, showing an operating revenue of $49.4 billion, up 14.3% year-over-year. Diluted earnings per share (EPS) were $7.72, down from $9.85 in 2Q 2024. The company also revised its full-year 2025 adjusted diluted EPS guidance to approximately $30.00. The financial performance was driven by higher premium yields and membership growth in its Health Benefits and Carelon segments, partially offset by elevated medical cost trends.
Profitelligence Alerts
Get alerts for ELV
Be first to know when Elevance Health Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Elevance Health Inc.
Elevance Health Inc., formerly known as Anthem, is a prominent health insurance company in the United States. Its primary function is to provide a wide range of health insurance products and related services to a diverse customer base, including individuals, families, and businesses. Elevance Health focuses on enhancing health and well-being by offering managed care plans tailored to the varying needs of its clients. With a robust portfolio, Elevance Health caters to multiple sectors within the healthcare industry, influencing stakeholders such as healthcare providers, pharmaceutical companies, and medical technology firms. The company plays a critical role in the healthcare market by negotiating coverage terms, managing costs, and ensuring policyholders have access to necessary medical services. As one of the largest health insurers in the nation, Elevance Health holds significant market influence, contributing to shaping healthcare policies and practices through its vast network and strategic partnerships. By leveraging technology and data analytics, the company aims to improve patient outcomes, streamline insurance processes, and foster advancements in personalized healthcare solutions.
Official SEC Documents
Advertisement